Latest News Releases From The Newsroom
Biogen: FDA Panel Backs OK of Alzheimer's Drug; Disc Medicine: Upgraded, Promising Trial Data
June 10th, 2023
Eisai and Biogen's (Nasdaq: BIIB) Alzheimer's drug candidate, LEQEMBI (lecanemab-irmb), received unanimous support from FDA PCNS panel based on Phase 3 Clarity AD trial data. The committee acknowledged its clinical benefit, overall benefit-r. Read more
GE Awarded up to $422.81M Contract; Primerica, CRISPR, Cineverse and Corning: PT Hiked
June 10th, 2023
General Electric Company's (NYSE: GE) subsidiary, GE Aerospace, has secured a significant contract from the Defense Logistics Agency Aviation for supplies related to the F-series engines (F101/110/118). The firm-fixed price, requirements-typ. Read more
23andMe: Strategic Move; Oracle, Tesla and Microsoft: PT Boost Hint at Potential Upsides
June 09th, 2023
23andMe Holding Co. (Nasdaq: ME), a leading genetic testing and personal genomics company, has disclosed in a regulatory filing with the SEC a reduction in force involving around 75 employees, representing approximately 9% of its workforce. . Read more
Pfizer to End License Deal with Theravance Bio; Truist Bullish On Vail Resorts and Leonardo DRS
June 09th, 2023
Theravance Biopharma Ireland Limited, an affiliate of Theravance Biopharma, Inc. (Nasdaq: TBPH), entered into a global license agreement with Pfizer Inc. (NYSE: PFE) in December 2019 for its preclinical skin-selective, locally acting pan-JAK inhibito. Read more
Aehr Test Systems Gets $13.7M in Orders; Fisker Targets Chinese Market
June 09th, 2023
Aehr Test Systems (Nasdaq: AEHR) has secured significant orders worth $13.7 million from a leading Fortune 500 semiconductor device supplier, who is a major player in the automotive semiconductor market. The orders are for Aehr's WaferPak fu. Read more
Vertex Pharma, CRISPR Surge On Exa-cel Trials Data; Sonoma Pharma Soars on Pulse Lavage Irrigation Solution
June 09th, 2023
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics AG (Nasdaq: CRSP) have announced positive results from pivotal trials for their investigational treatment, exagamglogene autotemcel (exa-cel), in patients with transfusion-dep. Read more
Canaccord Bullish on Joby Aviation, Lilium, Vertical Aerospace, Eve, Archer Aviation: eVTOL Stocks
June 09th, 2023
Joby Aviation, Inc. (NYSE: JOBY), a leading electric aviation company focused on the development of vertical takeoff and landing (VTOL) aircraft, has been initiated with a Buy rating and Price Target of $8 by Canaccord Genuity. With $JOBY cl. Read more
Braze, Duckhorn, General Motors, and Tesla: Earnings, Guidance, and Collaboration Updates
June 09th, 2023
Braze, Inc. (Nasdaq: BRZE) reported a first-quarter fiscal 2024 loss of $0.13 per share, better than the consensus estimate of a loss of $0.18 per share. The company has also provided guidance for the second quarter, expecting an adjusted lo. Read more
A Snapshot of Potential Upsides: Oculis, Zscaler, MercadoLibre, FIGS, Home Depot, AMETEK
June 09th, 2023
Oculis Holding AG (Nasdaq: OCS), a leading pharmaceutical company specializing in developing innovative therapies for ocular diseases, has been initiated with an Outperform rating and a price target of $58 by Robert W. Baird. With $OCS closing at . Read more
Raytheon Secures $372.14M Contract; FDA OKs Sientra's MRI-Compatible Tissue Expander AlloX2 Pro
June 08th, 2023
Raytheon Intelligence & Space, a key business segment of Raytheon Technologies Corp. (NYSE: RTX), has been awarded a significant contract worth $372,137,000 by the Naval Air Warfare Center Weapons Division. The contract entails updates, impr. Read more
Want To Find Some News?
News By Industries
Recent Posts
-
Micron Technology, Jabil, and Birkenstock Earnings Preview: What to Expect
December 15th, 2024Upcoming Earnings: Synopsys, AeroVironment, and nCino in Focus
December 01st, 2024Countdown to Earnings: Salesforce, Marvell Technology, and Okta Take the Stage
December 01st, 2024Fluence Energy, Agilent Technologies, and Woodward Earnings On Deck: A Preview
November 24th, 2024Earnings Preview: Walt Disney, Applied Materials, and Celcuity Take Center Stage
November 11th, 2024
Member Login